Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 2018 Nov 29

PMID 30484099

Citations 30

Authors

Min Wei

Wei Zhou

Yongyi Bi

Hong Wang

Yu Liu

Zhi-Jiang Zhang

Affiliations

Soon will be listed here.

Abstract

Background: In recent decades, much effort has been made in China to reduce the burden of cervical cancer.

Objective: Our study's purpose was to examine trends of cervical cancer mortality in each 5-year age group for urban and rural Chinese women, respectively.

Designs: Retrospective analysis of cervical cancer mortality from 1987 to 2015 from the World Health Organization Cancer Mortality Database and China Health Statistical Yearbooks.

Participants: Chinese women.

Main Measures: Trends were examined using annual percent change (APC) and average annual percent change (AAPC) via Joinpoint regression models for each 5-year age group in urban and rural areas, respectively.

Results: In urban China, mortality rate of cervical cancer increased significantly among urban women aged 25-54 years (AAPC 2.12~5.49%), in contrast to a decline trend among urban women older than 60 years (AAPC - 3.61~- 5.35%). In rural China, cervical cancer rates declined in all age groups, but the magnitude was smaller in women aged 30-54 years (AAPC - 0.59~- 2.20%) compared to women older than 55 years (AAPC - 3.06~- 4.33%).

Conclusion: Mortality rate of cervical cancer is rising at an alarming rate in younger women in urban China. Timely intervention is required for these vulnerable populations.

Citing Articles

ADAMDEC1 promotes cervical squamous cell carcinoma by enhancing the JAK/STAT signaling pathway through modulation of TYMP.

Wang B, Zhang Q, Wang L, Su H, Zhou L, Zhang R Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39625490 DOI: 10.1007/s00210-024-03680-w.

The role of circular RNA targeting IGF2BPs in cancer-a potential target for cancer therapy.

Luo X, Shi J, Wang S, Jin X J Mol Med (Berl). 2024; 102(11):1297-1314.

PMID: 39287635 DOI: 10.1007/s00109-024-02488-8.

Integrating Single-Cell RNA-Seq and Bulk RNA-Seq to Construct a Novel γδT Cell-Related Prognostic Signature for Human Papillomavirus-Infected Cervical Cancer.

Wang X, Jin Y, Xu L, Tao S, Wu Y, Ao C Cancer Control. 2024; 31:10732748241274228.

PMID: 39206965 PMC: 11363054. DOI: 10.1177/10732748241274228.

Human papilloma virus (HPV)-related information acquisition and seeking behavior among infected women: A single center cross-sectional survey in Shanghai, China.

Yuan X, Lu L, Jiang R, Yu Y, Zhou J, Wang L Glob Health Med. 2024; 6(3):212-217.

PMID: 38947411 PMC: 11197161. DOI: 10.35772/ghm.2023.01100.

Decoding Fujian's cervical HPV landscape: unmasking dominance of non-16/18 HR-HPV and tailoring prevention strategies at a large scale.

Zhang Y, Li H, You Q, Chen Y, Zhao Z, Chen J Front Public Health. 2024; 12:1357073.

PMID: 38903575 PMC: 11187235. DOI: 10.3389/fpubh.2024.1357073.

References

Wu S, Zhang W, Sun J, Li F, He Z, Zhou J . Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis. Int J Surg. 2017; 48:122-127. DOI: 10.1016/j.ijsu.2017.10.028. View

Lei H, Gui D, He Y . Short- and long-term outcomes of laparoscopic radical hysterectomy for obese patients with cervical cancer. J BUON. 2017; 22(4):958-965. View

Zou H, Wang W, Ma Y, Wang Y, Zhao F, Wang S . How university students view human papillomavirus (HPV) vaccination: A cross-sectional study in Jinan, China. Hum Vaccin Immunother. 2015; 12(1):39-46. PMC: 4962712. DOI: 10.1080/21645515.2015.1072667. View

Zhang Z, Li S . The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2014; 16(8):707-10. DOI: 10.1111/dom.12267. View

Huang T, Liu Y, Li Y, Liao Y, Shou Q, Zheng M . Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5 years of follow-up. Vaccine. 2018; 36(11):1368-1374. DOI: 10.1016/j.vaccine.2018.02.006. View

Torre L, Islami F, Siegel R, Ward E, Jemal A . Global Cancer in Women: Burden and Trends. Cancer Epidemiol Biomarkers Prev. 2017; 26(4):444-457. DOI: 10.1158/1055-9965.EPI-16-0858. View

Shen Y, Gong J, Li Y, Gong Y, Lei D, Cheng G . Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Henan Province, China. Clin Chim Acta. 2012; 415:297-301. DOI: 10.1016/j.cca.2012.11.005. View

Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F . Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66(2):115-32. DOI: 10.3322/caac.21338. View

Wang R, Guo X, Wisman G, Schuuring E, Wang W, Zeng Z . Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. BMC Infect Dis. 2015; 15:257. PMC: 4491249. DOI: 10.1186/s12879-015-0998-5. View

10.

Qiao Y, Sellors J, Eder P, Bao Y, Lim J, Zhao F . A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008; 9(10):929-36. DOI: 10.1016/S1470-2045(08)70210-9. View

11.

Wang L, Yu C, Liu Y, Wang J, Li C, Wang Q . Lung Cancer Mortality Trends in China from 1988 to 2013: New Challenges and Opportunities for the Government. Int J Environ Res Public Health. 2016; 13(11). PMC: 5129262. DOI: 10.3390/ijerph13111052. View

12.

Li X, Wang L, Li Y, Song P . The Value of Diffusion-Weighted Imaging in Combination With Conventional Magnetic Resonance Imaging for Improving Tumor Detection for Early Cervical Carcinoma Treated With Fertility-Sparing Surgery. Int J Gynecol Cancer. 2017; 27(8):1761-1768. DOI: 10.1097/IGC.0000000000001113. View

13.

Zhang Z, Zheng Z, Shi R, Su Q, Jiang Q, Kip K . Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012; 97(7):2347-53. DOI: 10.1210/jc.2012-1267. View

14.

Wu C, Zhu X, Kang Y, Cao Y, Lu P, Zhou W . Epidemiology of Humanpapilloma virus infection among women in Fujian, China. BMC Public Health. 2017; 18(1):95. PMC: 5543557. DOI: 10.1186/s12889-017-4651-7. View

15.

Jing L, Zhong X, Zhong Z, Huang W, Liu Y, Yang G . Prevalence of human papillomavirus infection in Guangdong Province, China: a population-based survey of 78,355 women. Sex Transm Dis. 2015; 41(12):732-8. DOI: 10.1097/OLQ.0000000000000201. View

16.

Pan Q, Hu S, Zhang X, Ci P, Zhang W, Guo H . Pooled analysis of the performance of liquid-based cytology in population-based cervical cancer screening studies in China. Cancer Cytopathol. 2013; 121(9):473-82. PMC: 3775994. DOI: 10.1002/cncy.21297. View

17.

Zheng B, Yang H, Li Z, Wei G, You J, Liang X . HPV test results and histological follow-up results of patients with LSIL Cervical Cytology from the Largest CAP-certified laboratory in China. J Cancer. 2017; 8(13):2436-2441. PMC: 5595072. DOI: 10.7150/jca.19421. View

18.

Wang Z, Wang J, Fang Y, Gross D, Wong M, Wong E . Parental acceptability of HPV vaccination for boys and girls aged 9-13 years in China - A population-based study. Vaccine. 2018; 36(19):2657-2665. DOI: 10.1016/j.vaccine.2018.03.057. View

19.

Fidler M, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F . Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. Lancet Oncol. 2017; 18(12):1579-1589. DOI: 10.1016/S1470-2045(17)30677-0. View

20.

Liu X, Bi Y, Wang H, Meng R, Zhou W, Zhang G . Different trends in colorectal cancer mortality between age groups in China: an age-period-cohort and joinpoint analysis. Public Health. 2018; 166:45-52. DOI: 10.1016/j.puhe.2018.08.007. View